Net income decreased 164.6%
Net income changed -164.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed -164.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -114.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating margin changed -2137 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed +223.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Stock-based compensation changed +38.9% from the comparable as-filed period.
Gross margin changed -220 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Inventory changed +19.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Cash & equivalents changed +10.4% from the comparable as-filed period.
Gross profit changed -6.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Revenue changed -4.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.